Issue Price
₹80
Per Share
GMP
NIL
Grey Market
Est. Listing
₹80
Expected Price
Min. Application
₹256,000
2 lots × 1600 shares
Incorporated in 2008, Tejnaksh Healthcare run an Institute of Urology, an ISO certified the international level Urology hospital. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.Tejnaksh Healthcare is equipped with all latest equipment and provide the whole range of services. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.Tejnaksh Healthcare is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to our patients in modern facilities. Company's operations are divided across four key vertical streams in healthcare delivery, namely - Pediatric Urology, Adult Urology (Male, Female), Andrology and Sexual Dysfunction and Nephrology, Dialysis and Renal Transplant.
Tejnaksh Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| TOTAL | 304,000 | 100.00% | ₹2.43 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹128,000 |
| Retail (Max) | 13 | 20,800 | ₹1,664,000 |
| sNII (Min) | 14 | 22,400 | ₹1,792,000 |
| bNII (Min) | 68 | 108,800 | ₹8,704,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |